...
首页> 外文期刊>Lancet Neurology >Plasma neurofilament light chain in the presenilin 1 E28OA autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study
【24h】

Plasma neurofilament light chain in the presenilin 1 E28OA autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study

机译:血浆神经丝轻链在Presenilin 1 E28OA常染色体占主导地位的阿尔茨海默病:横截面和纵向队列研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Neurofilament light chain (NfL) is a promising biomarker of active axonal injury and neuronal degeneration. We aimed to characterise cross-sectional and longitudinal plasma NfL measurements and determine the age at which NfL concentrations begin to differentiate between carriers of the presenilin 1 (PSEN1) E280A (Glu280Ala) mutation and age-matched non-carriers from the Colombian autosomal dominant Alzheimer's disease kindred. Methods In this cross-sectional and longitudinal cohort study, members of the familial Alzheimer's disease Colombian kindred aged 8-75 years with no other neurological or health conditions were recruited from the Alzheimer's Prevention Initiative Registry at the University of Antioquia (Medellin, Colombia) between Aug 1, 1995, and Dec 15, 2018. We used a single molecule array immunoassay and log-transformed data to examine the relationship between plasma NfL concentrations and age, and establish the earliest age at which NfL concentrations begin to diverge between mutation carriers and non-carriers.
机译:背景技术神经膜轻链(NFL)是有源轴突损伤和神经元变性的有希望的生物标志物。我们的旨在表征横截面和纵向血浆NFL测量并确定NFL浓度开始区分Presenilin 1(Psen1)E280A(Glu280Ala)突变和年龄匹配的非载体之间的年龄来自哥伦比亚常染色体优势阿尔茨海默氏症的突变的年龄疾病被视为。这种横断面和纵向队列研究中,家族阿尔茨海默氏病哥伦比亚的成员患者8-75岁,没有其他神经系统或健康状况,从Alzheimer的预防倡议登记处招募在Alzheimer的预防倡议登记处(哥伦比亚)之间的Alzheimer的预防倡议登记处1995年8月1日和2018年12月15日。我们使用单个分子阵列免疫测定和对数转换数据来检查血浆NFL浓度和年龄之间的关系,并建立最早的年龄,在突变载体之间开始发散的最早年龄非载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号